Storyline · Since November 9, 2026 · 23 articles
FDA GLP-1 Safety Review
From “FDA Orders GLP-1 Warning” to “GLP-1 Warnings Detail Vision-Loss Risk”.
26%
Left · 6
44%
Center · 10
30%
Right · 7
Pano counted 23 articles: 26% left-leaning, 44% center and 30% right-leaning. Pano rates its coverage Balanced.
Timeline
2 chaptersNov 10
GLP-1 Warnings Detail Vision-Loss Risk
The FDA’s required warnings for GLP-1 medicines address a rare eye condition that can cause sudden, permanent vision loss.
Balanced· 11 articlesNov 9
FDA Orders GLP-1 Warning
The FDA on Monday required GLP-1 drugmakers to add label warnings about a potential increased risk of a rare eye condition that can cause permanent vision loss.
Balanced· 12 articles
Both sides, every morning
Get this story’s next chapter, and how each side covered it, in the morning email.




















